Edit search
Letter regarding article by Tsimikas et al%2C %22high-dose a…
Letter regarding article by Tsimikas et al%2C %22high-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial%22.
Letter regarding article by Tsimikas et al%2C %22high-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial%22.
Article, Chapter
Authors: L.J.H. van Tits
Publication: Circulation, Volume:111, Issue:18
Published: Wolters Kluwer Health _ Lippincott Williams and Wilkins, 2005
ISSN: 0009-7322
  Full text availability for this item
Browse related articles
  Print copies at your library
  Request a copy of this item
Cite this item